The Tobacco Trade Came In From the Cold

The Tobacco Trade Came In From the Cold. Our Income Holdings Are Checking Its Coat.

British American Tobacco has doubled in two years — a better run than the Magnificent Seven — as new FDA guidance opens the pouch-and-vape lane and BAT’s U.S. pouch share more than doubled. Real yield, real re-rating, real ethics screens.

By Sean Anees Saifi · Capital Wealth · Published Friday, July 10, 2026 · Source: The Wall Street Journal, July 10, 2026

Key Points

British American Tobacco has doubled in two years — a better run than the Magnificent Seven.
New FDA guidance opened the pouch-and-vape lane; BAT’s U.S. pouch share hit 16.2%, from 6.7%.
Funds barred from owning the stock fell from 66% to 60% — excluded money is trickling back.
BTI goes under formal evaluation for our income holdings; ethics screens still apply.
No add today: a stock that already doubled owes you nothing.

BTI over the past two years

16.2%

U.S. pouch share, from 6.7% in a year

21x

Philip Morris earnings multiple, a 70% premium

60%

funds still excluding the stock, down from 66%

A single lit match against a dark background

In one line: BTI’s double is built on a real business shift, so it earns a formal review for our income holdings — but a stock that has already doubled owes you nothing.

British American Tobacco (BTI) has doubled in two years. The Journal notes, with a straight face, that this beats the Magnificent Seven.

It has company. Altria (MO) is up 50%. Philip Morris (PM) trades at 21 times earnings — a 70% premium.

Two years ago this was the market’s least fashionable aisle. Now the unfashionable aisle is outrunning the famous one, and it is worth asking why out loud.

Doubling quietly is still doubling. The polite thing is to notice. The professional thing is to ask what it means for income investors.

Why It Happened

This is not just a yield chase. The mechanism is a genuine business shift.

New FDA guidance opened the vape-and-pouch lane for the industry. BAT’s U.S. pouch share went from 6.7% to 16.2% in a single year.

Then there is the quieter driver. Institutional exclusions — big funds contractually barred from owning the stock — fell from 66% to 60%.

Read that again. Money that was not allowed to own tobacco is, slowly, allowed again. That is fuel no earnings report can print.

The result is a re-rating — investors agreeing to pay a higher price for the same dollar of profit. Yield got the story started; the re-rating did the doubling.

Pouches matter because they change the story funds tell their boards. A shrinking business gets a shrinking multiple. A business with a growing lane gets forgiven.

Evaluated, Not Chased

So BTI goes under formal evaluation for our income holdings. The yield is real. The re-rating runway is real. The doubling pouch share is real.

So are the ethics screens. Wherever a client mandate — your written instructions about what you will and won’t own — prohibits tobacco, it is excluded automatically. No exceptions, no debate.

Formal evaluation means the homework actually gets done: the yield, the runway, and what happens to the price if the re-rating stalls.

And there is no add today. Doubles get evaluated, not chased.

If the homework passes and the price cooperates, there will be time to act. If it does not, we will have lost nothing but a weekend.

The Discipline Part

A stock that has already doubled owes you nothing. That sentence does more work than any chart.

The right time to study a re-rating is before you decide whether you missed it. Study first, then decide. Never the other way around.

MO and PM stay reference points, not positions in the Capital Wealth Growth Portfolio. They tell us what the market will pay for steady cash flow right now, which is useful even when we are not buying.

Chasing feels productive because the chart is green. Evaluating feels slow because it is. Slow is what keeps retirement money out of other people’s victory laps.

None of this makes the product nicer. It makes the stock different, and those are separate questions a portfolio has to keep separate.

For clients, the takeaway is about process, not pouches. Every idea passes the same three gates: the math, the mandate, and the price already paid by the people who got there first.

What It Means For Your Portfolio

Under evaluation

BTI goes under formal evaluation for our income holdings — no add today.

The yield, the re-rating runway and the doubled pouch share are all real, and so are the ethics screens. It stays excluded wherever a client mandate prohibits it, no exceptions. MO and PM remain reference points, not positions, in the Capital Wealth Growth Portfolio — doubles get evaluated, not chased.